{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:31:58Z","timestamp":1779363118875,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbapap.2016.12.008","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T07:15:50Z","timestamp":1482131750000},"page":"261-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of sheep \u03b1-synuclein provides a molecular strategy for the reduction of fibrillation"],"prefix":"10.1016","volume":"1865","author":[{"given":"Lungisa","family":"Bickle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litsa","family":"Karageorgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2016.12.008_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0010","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"2180","key":"10.1016\/j.bbapap.2016.12.008_bb0040","first-page":"e2181","article-title":"Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0045","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/1074-5521(95)90071-3","article-title":"The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?","volume":"2","author":"Han","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0055","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0060","doi-asserted-by":"crossref","first-page":"15313","DOI":"10.1074\/jbc.M213128200","article-title":"A broken alpha -helix in folded alpha -Synuclein","volume":"278","author":"Chandra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0065","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"alpha-Synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5607\/en.2014.23.4.324","article-title":"Protein transmission, seeding and degradation: key steps for alpha-synuclein prion-like propagation","volume":"23","author":"Oueslati","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0075","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0080","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"7671","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in alpha-synuclein aggregation","volume":"Vol. 111","author":"Buell","year":"2014"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0085","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","article-title":"Alpha-Synuclein is degraded by both autophagy and the proteasome","volume":"278","author":"Webb","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0090","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"9322","article-title":"Cysteine cathepsins are essential in lysosomal degradation of alpha-synuclein","volume":"Vol. 112","author":"McGlinchey","year":"2015"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0095","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0100","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","article-title":"Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease","volume":"799","author":"Hashimoto","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0110","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"4897","article-title":"Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation","volume":"Vol. 97","author":"Serpell","year":"2000"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0115","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/bi001315u","article-title":"Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein","volume":"39","author":"Rochet","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-010-9230-3","article-title":"Gaucher disease in sheep","volume":"34","author":"Karageorgos","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2016.03.011","article-title":"Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease","volume":"91","author":"Karageorgos","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0130","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/nprot.2008.133","article-title":"Touchdown PCR for increased specificity and sensitivity in PCR amplification","volume":"3","author":"Korbie","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0135","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1111\/febs.12471","article-title":"alpha-Synuclein as an intrinsically disordered monomer\u2013fact or artefact?","volume":"280","author":"Coelho-Cerqueira","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ab.2010.02.001","article-title":"Strategies to increase the reproducibility of protein fibrillization in plate reader assays","volume":"400","author":"Giehm","year":"2010","journal-title":"Anal. Biochem."},{"issue":"Pt 3","key":"10.1016\/j.bbapap.2016.12.008_bb0150","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3460577","article-title":"Alpha-synuclein overexpression promotes aggregation of mutant huntingtin","volume":"346","author":"Furlong","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0155","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","article-title":"Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes","volume":"273","author":"Davidson","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmb.2008.05.013","article-title":"Prediction of aggregation-prone regions in structured proteins","volume":"380","author":"Tartaglia","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0170","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/bi00032a006","article-title":"Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic","volume":"34","author":"Iwai","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0175","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.0915166107","article-title":"Identifying the amylome, proteins capable of forming amyloid-like fibrils","volume":"107","author":"Goldschmidt","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0180","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jmb.2014.09.026","article-title":"The CamSol method of rational design of protein mutants with enhanced solubility","volume":"427","author":"Sormanni","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human alpha-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0190","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1021\/bi010616g","article-title":"Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein","volume":"40","author":"Li","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0195","doi-asserted-by":"crossref","first-page":"13465","DOI":"10.1021\/ja203979j","article-title":"The A53T mutation is key in defining the differences in the aggregation kinetics of human and mouse alpha-synuclein","volume":"133","author":"Kang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0200","series-title":"Factors Affecting the Fibrillation of \u03b1-Synuclein, a Natively Unfolded Protein, Misbehaving Proteins: Protein (Mis)Folding, Aggregation, and Stability","first-page":"265","author":"Fink","year":"2006"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0205","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ymeth.2010.12.008","article-title":"Assays for alpha-synuclein aggregation","volume":"53","author":"Giehm","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.3457","article-title":"Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases","volume":"20","author":"Guo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0220","first-page":"1","article-title":"Amyloid peptides and proteins in review","volume":"159","author":"Harrison","year":"2007","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.131","article-title":"Amyloid formation by globular proteins under native conditions","volume":"5","author":"Chiti","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1432-1327.1998.2580157.x","article-title":"The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils","volume":"258","author":"El-Agnaf","year":"1998","journal-title":"Eur. J. Biochem.\/FEBS"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0235","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1021\/bi034028+","article-title":"A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein","volume":"42","author":"Du","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0240","first-page":"132","article-title":"New alpha- and gamma-synuclein immunopathological lesions in human brain","volume":"2","author":"Surgucheva","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1471-4159.2001.00408.x","article-title":"Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity","volume":"78","author":"Bodles","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0250","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbapap.2016.12.008_bb0260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn2477","article-title":"Research in motion: the enigma of Parkinson's disease pathology spread","volume":"9","author":"Brundin","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbapap.2016.12.008_bb0265","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916302655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963916302655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:17:28Z","timestamp":1658107048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963916302655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1570963916302655"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.12.008","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of sheep \u03b1-synuclein provides a molecular strategy for the reduction of fibrillation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}